PPT-MYCOPHENOLATE MOFETIL FOR FIRST-LINE TREATMENT OF IMMUNE THROMBOCYTOPENIA

Charlotte A Bradbury Julie Pell Published in nejm on 02 sep 2021 INTRODUCTION Immune thrombocytopenia is a rare condition with an incidence in adults of 29 per . The immune mediated form can lead to thrombo sis and the need to consider alternative therapies Types of hepari n related thrombocytopenia HAT Non immune Mediated HIT Immune Mediated Frequency 10 30 1 3 Timing of Onset 4 days Typical 5 10 days Acute Joanna Rupa-Matysek. Hemostatic. System - . general. . information. Normal . hemostatic. system . vessel wall. circulating blood platelets. blood coagulation and . fibrynolysis. Bleeding. . Diathesis. (HIT). HEPARIN-INDUCED THROMBOCYTOPENIA. Unfractionated heparin (UFH) (beef > pork). Continuous iv infusion. Cardiopulmonary bypass. Low dose sq. Heparin flushes. Heparin-bonded catheters. Low molecular weight heparin. Richard J. Barohn, MD. Chair, Department of Neurology. Gertrude and Dewey Ziegler Professor of Neurology. University Distinguished Professor. Vice Chancellor for Research. University of Kansas Medical Center. Articles. by . Ryan Burris, Ali Naqvi, Wendy Yang. Presentation. by . Sam . Lai, Alex . Raufi. Questions. by . Vicki Cheng. Definition. Mild: 100 to 150. Moderate. : 50 to 100. Severe. : < 50. Keep in mind, these are 95% confidence intervals, so 2.5% of population < 150. limba. . engleza. 2012-2013. Background. 1/3 of all Hematology Consults in a General Hospital are for . thrombocytopenia. 5 to 10% of all hospital patients are thrombocytopenic in the ICU the number increases to 35. August, 2014. Immunopharmacology. Munir Gharaibeh, MD, PhD, MHPE.. August, 2014. Immunopharmacology. Immunosuppressive Agents.. Immunomodulation Therapy.. Immunologic Reactions to Dugs.. Immunosuppressive Agents. 30 September 2019 Pharmaceuticals Creating a global growth platform in haematology In order to utilise the ‘Safe Harbor’ provisions of the United States Private Securities Litigation Reform Ac New Drug Application for DOPTELETavatrombopag for Treatment ofChronic Immune Thrombocytopenia ITPCompany Strengthens Thrombocytopenia Portfolio with ITP Approvaland ExpandedPartnership with Salix for Idiopathic Thrombocytopenic PurpuraJune 26 2019May 2019Thrombocytopenia May 21 2018May 2019 2 Drug InformationRegulatory InformationManufacturerDova PharmaceuticalsApplication TypeSupplemental NDAD Novartis Singapore . P3 approval #. SG2010199741 Exp. 18-Oct-2022. Disclaimer. “This presentation/slide deck may include data on an indication that has not been approved or cleared for use in Singapore by the Health Sciences Authority. It is intended to provide you with pertinent scientific data to form your own conclusions and make your own decisions. Information in this presentation/slide deck is not intended to be promoting or recommending any indication, dosage or other claim not covered in the licensed product information. Novartis does not support the promotion of its products in a manner inconsistent with its approved labelling.”. in a young girl. Dr.Manoj. . Prakash.J. JR-II. Dept. of Medicine. HISTORY. A 16 Yrs old female patient came to . casulty. . c/o . massive Per vaginal bleeding since 15 days. . She also complained of giddiness and breathlessness on . . jithin. P JR1 Medicine. introduction. P. latelets. are one of the blood cells that are released from megakaryocytes. Hypertension/ Adjunct for Ischaemic Heart Disease/Diabetes. . Lisinopril . Zestril Tablets 20mg - 56s. $. 25.64. Mycophenolate Sandoz Tablets 250mg - 50s. New Active Pharmaceutical Ingredient .